Cleared Abbreviated

K100129 - AMBU BLUE SENSOR NEO, AMBU BLUE SENSOR NEO X

K100129 is an FDA 510(k) clearance for AMBU BLUE SENSOR NEO, manufactured by Ambu A/S. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Abbreviated 510(k) pathway after a 143-day FDA review.

K100129 · Ambu A/S · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2010
Decision
143d
Days
Class 2
Risk

K100129 is an FDA 510(k) clearance for the AMBU BLUE SENSOR NEO, AMBU BLUE SENSOR NEO X. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Ambu A/S (Glen Burnie, US). The FDA issued a Cleared decision on June 11, 2010 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

FDA 510(k) Submission Details - K100129

510(k) Number K100129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2010
Decision Date June 11, 2010
Days to Decision 143 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 125d · This submission: 143d
Pathway characteristics
Standards-based clearance path.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 324
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K100129.
BIOMODULE 3-M1
K123658 · Zephyr Technology Corporation · Apr 2013
CENTERRIDGE DIAGNOSTIC ECG ELECTRODE, CENTERRIDGE MONITORING ECG ELECTRODES
K101576 · Team Innovations, Inc. · Jul 2010
IP-SET
K101685 · Integral Process Sas · Jul 2010
INTCO TAB ELECTRODE
K093327 · Shanghai Intco Electrode Manufacturing Co., Ltd. · May 2010
12 LEAD GLOVE
K100315 · I Needmd, Inc. · Apr 2010
NEONATAL ECG ELECTRODE, M203KEN
K092744 · R & D Medical Products, Inc. · Dec 2009
K100129 · AMBU BLUE SENSOR NEO, AMBU BLUE SENSOR NEO X
Download PDF FDA Summary Ambu A/S